Codexis (CDXS) +11.4% AH after signing an exclusive negotiation agreement with Royal Dutch Shell (RDS.A, RDS.B) which would grant to CDXS certain rights and licenses in the biofuels field to develop and sell cellulase enzymes to third parties on a worldwide basis except Brazil.
Codexis (CDXS) +11.4% AH after signing an exclusive negotiation agreement with Royal Dutch Shell...
ETF Screener: Search and filter by asset class, strategy, theme, performance, yield, and much more
ETF Performance: View ETF performance across key asset classes and investing themes
ETF Investing Guide: Learn how to build and manage a well-diversified, low cost ETF portfolio
ETF Selector: An explanation of how to select and use ETFs